CAPTRUST Financial Advisors
BSTC

CAPTRUST Financial Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,295
Closed -$69K – 3618
2020
Q3 		$69K Buy
1,295
+380
+42% +$23.5K ﹤0.01% 1519
2020
Q2 		$58K Buy
+915
New +$52.9K ﹤0.01% 1573

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CAPTRUST Financial Advisors's BSTC Position: Q4 2020 in Review

CAPTRUST Financial Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 1,295 shares — an estimated $69K sold.

CAPTRUST Financial Advisors first reported a position in BSTC in Q2 2020 and held it in 2 quarters. The position peaked at $69K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • CAPTRUST Financial Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,295 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $69K.
  • CAPTRUST Financial Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2020 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's BioSpecifics Technologies Corp. position peaked at $69K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.